Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/11/e003293.full |
| _version_ | 1818988407108403200 |
|---|---|
| author | Bram Van Den Eeckhout Leander Huyghe Sandra Van Lint Elianne Burg Stéphane Plaisance Frank Peelman Anje Cauwels Gilles Uzé Niko Kley Sarah Gerlo Jan Tavernier |
| author_facet | Bram Van Den Eeckhout Leander Huyghe Sandra Van Lint Elianne Burg Stéphane Plaisance Frank Peelman Anje Cauwels Gilles Uzé Niko Kley Sarah Gerlo Jan Tavernier |
| author_sort | Bram Van Den Eeckhout |
| collection | DOAJ |
| first_indexed | 2024-12-20T19:22:05Z |
| format | Article |
| id | doaj.art-d36241b88658437b966c5cf4b40f4553 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-20T19:22:05Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-d36241b88658437b966c5cf4b40f45532022-12-21T19:28:58ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-0191110.1136/jitc-2021-003293Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradicationBram Van Den Eeckhout0Leander Huyghe1Sandra Van Lint2Elianne Burg3Stéphane Plaisance4Frank Peelman5Anje Cauwels6Gilles Uzé7Niko Kley8Sarah Gerlo9Jan Tavernier10VIB-UGent Center for Medical Biotechnology, Ghent, BelgiumVIB-UGent Center for Medical Biotechnology, Ghent, BelgiumVIB-UGent Center for Medical Biotechnology, Ghent, BelgiumVIB-UGent Center for Medical Biotechnology, Ghent, BelgiumVIB Nucleomics Core, Leuven, BelgiumVIB-UGent Center for Medical Biotechnology, Ghent, BelgiumVIB-UGent Center for Medical Biotechnology, Ghent, BelgiumIRMB, University Montpellier, INSERM, CNRS, Montpellier, FranceOrionis Biosciences Inc, Waltham, Massachusetts, USAVIB-UGent Center for Medical Biotechnology, Ghent, BelgiumVIB-UGent Center for Medical Biotechnology, Ghent, Belgiumhttps://jitc.bmj.com/content/9/11/e003293.full |
| spellingShingle | Bram Van Den Eeckhout Leander Huyghe Sandra Van Lint Elianne Burg Stéphane Plaisance Frank Peelman Anje Cauwels Gilles Uzé Niko Kley Sarah Gerlo Jan Tavernier Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication Journal for ImmunoTherapy of Cancer |
| title | Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication |
| title_full | Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication |
| title_fullStr | Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication |
| title_full_unstemmed | Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication |
| title_short | Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication |
| title_sort | selective il 1 activity on cd8 t cells empowers antitumor immunity and synergizes with neovasculature targeted tnf for full tumor eradication |
| url | https://jitc.bmj.com/content/9/11/e003293.full |
| work_keys_str_mv | AT bramvandeneeckhout selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT leanderhuyghe selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT sandravanlint selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT elianneburg selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT stephaneplaisance selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT frankpeelman selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT anjecauwels selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT gillesuze selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT nikokley selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT sarahgerlo selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication AT jantavernier selectiveil1activityoncd8tcellsempowersantitumorimmunityandsynergizeswithneovasculaturetargetedtnfforfulltumoreradication |